Humana (HUM) Stock Price
Humana Price
Humana (HUM) Stock | ISIN US4448591028 | WKN 856584. The current Humana stock price is 383.84 USD (2026). Revenue is 162.52 B USD. Net income is 1.11 B USD. The P/E ratio is 41.73. Market capitalization is 46.08 B USD. Humana operates in the Health sector.
Over the last 19 years Humana grew revenue by 9.9% annually, reaching 129.66 B USD. Earnings per share have grown at 6.6% per year over the last 19 years. For Humana, the net margin of 0.9% is down versus 3.5% a few years ago. At today's price the dividend yield works out to roughly 0.92%. The payout ratio is around 13% of earnings. The dividend has grown at 11.7% per year over the past 14 years.
Humana stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Humana over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Humana stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Humana's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Humana Price |
|---|
Humana Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Income Statement, Balance Sheet, Cash Flow Statement
| REVENUE (B USD) |
|---|
| REVENUE GROWTH (%) |
| GROSS MARGIN (%) |
| GROSS INCOME (M USD) |
| NET INCOME (B USD) |
| NET INCOME GROWTH (%) |
| DIVIDEND (USD)DIV. (USD) |
| DIVIDEND GROWTH (%)DIV. GROWTH (%) |
| SHARES (M) |
| DOCUMENTS |
| 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e | 2031e |
|---|---|---|---|---|---|---|---|
| 117.76 | 129.66 | 162.52 | 172.44 | 185.46 | 201.04 | 215.15 | 242.82 |
| 10.7 | 10.11 | 25.34 | 6.11 | 7.55 | 8.4 | 7.02 | 12.86 |
| - | - | - | - | - | - | - | - |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 1.21 | 1.19 | 1.11 | 1.85 | 3.08 | 4.5 | 4.13 | 4.29 |
| -51.51 | -1.57 | -6.48 | 66.25 | 66.76 | 46.17 | -8.24 | 3.82 |
| 3.54 | 3.54 | 3.54 | 1.99 | 3.32 | - | - | - |
| – | – | – | -43.79 | 66.83 | – | – | – |
| 120.87 | 120.83 | 120.83 | 120.83 | 120.83 | 120.83 | 120.83 | 120.83 |
| – | – | – | – | – | – | – | – |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Humana generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Humana retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Humana's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Humana has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Humana's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Humana stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana business model & stock analysis
Humana SWOT Analysis
Strengths
Humana Inc. has established a strong market position in the healthcare industry, particularly in the health insurance sector. This strong presence gives the company a competitive advantage and enhances its brand value.
Humana offers a diverse range of health insurance products and services, including individual and group coverage plans, Medicare, and Medicaid plans. This diverse product portfolio allows the company to cater to a wide range of customer needs.
Weaknesses
A significant portion of Humana's revenue comes from government-sponsored healthcare programs such as Medicare and Medicaid. The company's heavy reliance on these programs exposes it to changes in government regulations and policies, which can impact its financial performance.
Humana's operations are mainly focused in the United States. While this allows the company to have a deep understanding of the local market, it also limits its growth potential in international markets. Expanding into new geographic regions could be a challenge for the company.
Opportunities
The increasing aging population creates a significant opportunity for Humana. With its expertise in Medicare and other senior-focused healthcare plans, the company can benefit from the growing demand for healthcare services among the elderly population.
Rapid advancements in technology present opportunities for Humana to improve its healthcare delivery systems, enhance customer experience, and streamline its operations. Embracing technologies like telemedicine and digital health solutions can give the company a competitive edge.
Threats
The healthcare industry is highly competitive, with multiple players vying for market share. Humana faces competition from other health insurers, as well as from hospitals, healthcare providers, and new entrants to the market. This competitive landscape poses a threat to the company's growth and profitability.
The healthcare industry is heavily regulated, and changes in government regulations and policies can significantly impact Humana's operations and profitability. Moreover, political uncertainty and debates surrounding healthcare reform can create challenges and uncertainties for the company's future.
Humana Segments
Humana Revenue by Segment (1/2)
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Revenue by Segment (2/2)
3 Years
Max
Details
Humana Eulerpool Fair Value
Humana historical P/E ratio, EBIT multiple, and P/S ratio
Humana annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Humana shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Dividend History
20 years of dividend payments
Humana dividend history and estimates
Max
Details
Humana dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Humana Earnings Estimates
Humana Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 4/29/2026 | 10.13USD | 39.76 BUSD | 2026 Q1 |
| 2/11/2026 | -4.05USD | 32.4 BUSD | 2025 Q4 |
| 4/24/2024 | 10.38USD | 28.86 BUSD | 2024 Q1 |
| 1/30/2024 | 2.2USD | 25.79 BUSD | 2023 Q4 |
| 7/25/2023 | 8.99USD | 25.88 BUSD | 2023 Q2 |
| 4/25/2023 | 8.75USD | 26.18 BUSD | 2023 Q1 |
| 1/31/2023 | 1.49USD | 22.82 BUSD | 2022 Q4 |
| 11/2/2022 | 6.35USD | 23.1 BUSD | 2022 Q3 |
| 7/27/2022 | 7.75USD | 23.82 BUSD | 2022 Q2 |
| 4/27/2022 | 6.85USD | 23.86 BUSD | 2022 Q1 |
EESG©
Eulerpool ESG Scorecard© for the Humana stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Humana shareholder structure
| % | Name |
|---|---|
11.83096% | |
9.40478% | |
5.4229% | |
4.84632% | |
4.55023% | |
3.69159% | |
3.39209% | |
2.99853% | |
2.71087% | |
2.6527% |
Humana Executives and Management Board
Mr. David Dintenfass
(54)President - Enterprise Growth
Mr. James Rechtin
(54)President, Chief Executive Officer, Director · since 2024
Dr. Sanjay Shetty
(51)President - CenterWell
Mr. George Renaudin
(56)President - Insurance
Mr. Joseph Ventura
(47)Chief Legal Officer
Humana Supply Chain
Frequently asked questions about Humana
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana stock
Humana Ticker
Humana FIGI
All fundamentals and in-depth analysis of Humana
Our stock analysis for Humana Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Humana Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.